A detailed history of Garde Capital, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Garde Capital, Inc. holds 666 shares of BAX stock, worth $20,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
666
Holding current value
$20,266
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 22, 2025

BUY
$29.26 - $36.57 $19,487 - $24,355
666 New
666 $22,000
Q1 2024

May 29, 2024

BUY
$37.88 - $43.77 $89,624 - $103,559
2,366 New
2,366 $101,000
Q2 2023

Aug 28, 2023

SELL
$39.98 - $47.68 $5,357 - $6,389
-134 Reduced 5.36%
2,366 $108,000
Q1 2022

May 27, 2022

SELL
$76.85 - $89.45 $24,207 - $28,176
-315 Reduced 11.19%
2,500 $194,000
Q2 2020

Sep 02, 2020

BUY
$78.66 - $94.14 $24,777 - $29,654
315 Added 12.6%
2,815 $242,000
Q1 2019

May 08, 2019

BUY
$64.48 - $81.31 $161,200 - $203,275
2,500 New
2,500 $203,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $15.3B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Garde Capital, Inc. Portfolio

Follow Garde Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Garde Capital, Inc. with notifications on news.